Core Scientific [CORZZ] vs Oracle [ORCL] Detailed Stock Comparison
Core Scientific
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Core Scientific wins in 7 metrics, Oracle wins in 6 metrics, with 0 ties. Core Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Core Scientific | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 66.08 | N/A |
| Price-to-Book Ratio | N/A | 33.66 | N/A |
| Debt-to-Equity Ratio | -1.09 | 452.53 | Core Scientific |
| PEG Ratio | N/A | -35.02 | N/A |
| EV/EBITDA | 3.36 | 37.37 | Core Scientific |
| Profit Margin (TTM) | 23.71% | 21.08% | Core Scientific |
| Operating Margin (TTM) | -28.13% | 31.38% | Oracle |
| EBITDA Margin (TTM) | N/A | 31.38% | N/A |
| Return on Equity | 160.33% | 69.24% | Core Scientific |
| Return on Assets (TTM) | -6.74% | 7.15% | Oracle |
| Free Cash Flow (TTM) | $-52.30M | $-394.00M | Core Scientific |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 46.67% | 67.47% | Oracle |
| Price-to-Sales Ratio (TTM) | 0.00 | 13.82 | Core Scientific |
| Enterprise Value | $363.57M | $914.26B | Oracle |
| EV/Revenue Ratio | 0.71 | 15.49 | Core Scientific |
| Gross Profit Margin (TTM) | 6.39% | 67.28% | Oracle |
| Revenue per Share (TTM) | $1 | $21 | Oracle |
| Earnings per Share (Diluted) | N/A | $4.33 | N/A |
| Beta (Stock Volatility) | N/A | 1.53 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Core Scientific vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Core Scientific | 0.78% | 6.06% | 31.83% | -0.83% | 156.10% | 23.87% |
| Oracle | 1.90% | 0.95% | 28.06% | 20.57% | 108.51% | 72.34% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Core Scientific | 46.67% | 962.50% | 962.50% | 962.50% | 962.50% | 962.50% |
| Oracle | 67.47% | 352.11% | 367.93% | 651.02% | 921.93% | 2,288.48% |
News Based Sentiment: Core Scientific vs Oracle
Core Scientific
News based Sentiment: MIXED
September was a month of conflicting signals for Core Scientific. While analysts maintained a 'Buy' consensus and an insider made a significant purchase, the company reported a substantial loss and a revenue decline. The potential challenges surrounding the CoreWeave acquisition add another layer of complexity, making it a pivotal moment for the company's future.
Oracle
News based Sentiment: MIXED
October was a pivotal month for Oracle, marked by a massive surge in RPO driven by the OpenAI partnership, but also overshadowed by concerns about rising debt, high valuation, and insider selling. The mixed analyst reactions and regulatory scrutiny add to the complexity, making it a significant month for investors to reassess the risk-reward profile.
Performance & Financial Health Analysis: Core Scientific vs Oracle
| Metric | CORZZ | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $819.55B |
| Market Cap Category | Micro cap | Mega cap |
| 10 Day Avg. Volume | 77,939 | 28,166,510 |
| 90 Day Avg. Volume | 45,835 | 29,452,477 |
| Last Close | $17.99 | $291.59 |
| 52 Week Range | $6.32 - $18.56 | $118.86 - $345.72 |
| % from 52W High | -3.07% | -15.66% |
| All-Time High | $18.56 (Nov 25, 2024) | $345.72 (Sep 10, 2025) |
| % from All-Time High | -3.07% | -15.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.44% | 0.12% |
| Quarterly Earnings Growth | -0.44% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 0.21% |
| Operating Margin (TTM) | -0.28% | 0.31% |
| Return on Equity (TTM) | 1.60% | 0.69% |
| Debt to Equity (MRQ) | -1.09 | 452.53 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-3.51 | $8.50 |
| Cash per Share (MRQ) | $1.90 | $3.87 |
| Operating Cash Flow (TTM) | $12.92M | $21.53B |
| Levered Free Cash Flow (TTM) | $-73,454,624 | $-2,832,250,112 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: Core Scientific vs Oracle
| Metric | CORZZ | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 66.08 |
| Forward P/E | N/A | 39.96 |
| PEG Ratio | N/A | -35.02 |
| Price to Sales (TTM) | 0.00 | 13.82 |
| Price to Book (MRQ) | N/A | 33.66 |
| Market Capitalization | ||
| Market Capitalization | $0 | $819.55B |
| Enterprise Value | $363.57M | $914.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.71 | 15.49 |
| Enterprise to EBITDA | 3.36 | 37.37 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.53 |
| Book Value per Share (MRQ) | $-3.51 | $8.50 |
Financial Statements Comparison: Core Scientific vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CORZZ | ORCL |
|---|---|---|
| Revenue/Sales | $79.53M | $15.90B |
| Cost of Goods Sold | $71.31M | $4.74B |
| Gross Profit | $8.21M | $11.16B |
| Research & Development | N/A | $2.65B |
| Operating Income (EBIT) | $-42.59M | $5.19B |
| EBITDA | $-641.64M | $7.00B |
| Pre-Tax Income | $580.90M | $4.15B |
| Income Tax | $205,000 | $725.00M |
| Net Income (Profit) | $580.69M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CORZZ | ORCL |
|---|---|---|
| Cash & Equivalents | $697.94M | $10.79B |
| Total Current Assets | $833.18M | $24.58B |
| Total Current Liabilities | $195.51M | $32.64B |
| Long-Term Debt | $1.17B | $96.83B |
| Total Shareholders Equity | $-181.51M | $20.97B |
| Retained Earnings | $-3.15B | $-15.48B |
| Property, Plant & Equipment | $610.44M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CORZZ | ORCL |
|---|---|---|
| Operating Cash Flow | $590.74M | $5.93B |
| Capital Expenditures | $-88.42M | N/A |
| Free Cash Flow | $-129.06M | $-2.92B |
| Debt Repayment | $-4.46M | $-6.07B |
| Common Stock Repurchase | N/A | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CORZZ | ORCL |
|---|---|---|
| Shares Short | N/A | 23.58M |
| Short Ratio | N/A | 0.97 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 77,939 | 28,166,510 |
| Average Daily Volume (90 Day) | 45,835 | 29,452,477 |
| Shares Outstanding | 292.61M | 2.81B |
| Float Shares | 278.10M | 1.67B |
| % Held by Insiders | N/A | 0.41% |
| % Held by Institutions | N/A | 0.45% |
Dividend Analysis & Yield Comparison: Core Scientific vs Oracle
| Metric | CORZZ | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |